Inodiftagene Vixteplasmid

Inodiftagene Vixteplasmid · Anchiano Therapeutics Israel Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inodiftagene Vixteplasmid, covering 2020-08-19 to 2020-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC [Phase 2]